Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 10, 2022
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
Tue, August 9, 2022
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
Robert Burns Maintained (SWTX) at Strong Buy with Decreased Target to $94 on, Aug 9th, 2022
Robert Burns of HC Wainwright & Co., Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Decreased Target from $95 to $94 on, Aug 9th, 2022.
Robert has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- David Nierengarten of "Wedbush" Maintained at Buy with Decreased Target to $50 on, Friday, May 27th, 2022
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $82 on, Tuesday, May 24th, 2022
